首页> 外国专利> METHOD FOR PREDICTING A CLINICAL COURSE OF EARLY NEUROSYPHILIS IN HIV-INFECTED PATIENTS

METHOD FOR PREDICTING A CLINICAL COURSE OF EARLY NEUROSYPHILIS IN HIV-INFECTED PATIENTS

机译:预测HIV感染患者中早期神经病的临床过程的方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely venerology, and can be used to predict a clinical course of early neurosyphilis in an HIV-infected patient. That is ensured by determining clinical form of neurosyphilis, availability of antiretroviral therapy, micro-precipitation reaction (MPR) and determining the titre value MPR blood. Grading and numerical values are established to detect risk factors, after which prognostic coefficients F1, F2 and F3 by formulas. At maximum value F1 regredient version is predicted, with maximum value F2 – stationary version, and at maximum value F3 – progredient clinical version of early neurosyphilis.;EFFECT: method enables providing more effective and targeted preventive and therapeutic measures in the groups of patients with a high risk of the re-competitive and stationary versions of early neurosyphilis due to accuracy up to 98 % of the individual prognosis of developing the clinical course of early neurosyphilis in the HIV-infected patient in nearest 5-year period after the diagnosis.;1 cl, 3 ex
机译:技术领域本发明涉及医学,即性病学,并且可以用于预测HIV感染患者中早期神经梅毒的临床过程。通过确定神经梅毒的临床形式,抗逆转录病毒疗法的可用性,微沉淀反应(MPR)并确定MPR血液的滴定度值,可以确保这一点。建立分级和数值以检测风险因素,然后通过公式计算预后系数F 1 ,F 2 和F 3 。预测最大值为F 1 的版本,最大值为F 2 –固定版本,最大值为F 3 –熟练的临床版本效果:该方法能够为具有较高竞争性和固定性早期神经梅毒风险的患者群体提供更有效,针对性更强的预防和治疗措施,因为其准确率高达98%的个体预后在诊断后的最近5年内发展HIV感染患者的早期神经梅毒的临床过程。1cl,3 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号